The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Results from the phase III frontMIND trial show that adding tafasitamab and lenalidomide to R-CHOP…
Results from the first randomized controlled trial of a multi-cancer early detection (MCED) test suggest…
At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) David Reardon, MD, director…
For cancer survivors experiencing overall mood disturbance, anxiety, fatigue, or insomnia, regular gentle hatha and…
A new randomied clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster…
In a randomized phase 2 clinical trial, patients who received the experimental drug elraglusib, alongside…
The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favourable safety…
Primary liver cancer continues to pose a major global health challenge, ranking as the third…
New findings have identified a potential association between COVID-19 and increased lung cancer risk, driven…
Survivors of cancer in their teen and young adult years are at double the risk…